Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Critical Reviews in Eukaryotic Gene Expression|April 5, 2023
Spatiotemporal Epigenetic Control of the Histone Gene Chromatin Landscape during the Cell CycleAndrew J Fritz, Prachi N Ghule, Rabail Toor, et al.
The Journal of Biological Chemistry|October 13, 2012
miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cellsMohammad Q Hassan, Yukiko Maeda, Hanna Taipaleenmaki, et al.
Biomaterials Advances|January 11, 2022
Titanium with nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by regulating histone methylationRayana L Bighetti-Trevisan, Luciana O Almeida, Larissa M S Castro-Raucci, et al.
Bone Reports|August 18, 2023
Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiationParisa Dashti, Eric A Lewallen, Jonathan A R Gordon, et al.
Scientific Reports|November 21, 2023
LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fateJonathan A R Gordon, Coralee E Tye, Bodhisattwa Banerjee, et al.
Bone|February 10, 2024
Epigenetic regulators controlling osteogenic lineage commitment and bone formationParisa Dashti, Eric A Lewallen, Jonathan A R Gordon, et al.
Nucleic Acids Research|August 15, 2014
The bone-specific Runx2-P1 promoter displays conserved three-dimensional chromatin structure with the syntenic Supt3h promoterA Rasim Barutcu, Phillip W L Tai, Hai Wu, et al.
Scientific Reports|May 13, 2022
LncMIR181A1HG is a novel chromatin-bound epigenetic suppressor of early stage osteogenic lineage commitmentCoralee E Tye, Prachi N Ghule, Jonathan A R Gordon, et al.
Plos One|July 21, 2022
Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cellsTerri L Messier, Joseph R Boyd, Jonathan A R Gordon, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2016
MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cellsGillian Browne, Julie A Dragon, Deli Hong, et al.
Pageof 16